GB9903090D0 - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
GB9903090D0
GB9903090D0 GBGB9903090.0A GB9903090A GB9903090D0 GB 9903090 D0 GB9903090 D0 GB 9903090D0 GB 9903090 A GB9903090 A GB 9903090A GB 9903090 D0 GB9903090 D0 GB 9903090D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic compounds
therapeutic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9903090.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9903090.0A priority Critical patent/GB9903090D0/en
Publication of GB9903090D0 publication Critical patent/GB9903090D0/en
Priority to DK00905043T priority patent/DK1150988T3/en
Priority to PCT/EP2000/001045 priority patent/WO2000047591A1/en
Priority to CA002362662A priority patent/CA2362662A1/en
Priority to KR1020017010198A priority patent/KR20010102082A/en
Priority to AU26713/00A priority patent/AU772478B2/en
Priority to TNTNSN00029A priority patent/TNSN00029A1/en
Priority to CZ20012908A priority patent/CZ20012908A3/en
Priority to ES00905043T priority patent/ES2200820T3/en
Priority to CN 200410001601 priority patent/CN1803810A/en
Priority to DE60002986T priority patent/DE60002986T2/en
Priority to PT00905043T priority patent/PT1150988E/en
Priority to ARP000100596A priority patent/AR031975A1/en
Priority to PE2000000100A priority patent/PE20001462A1/en
Priority to PL350023A priority patent/PL204458B1/en
Priority to EP00905043A priority patent/EP1150988B1/en
Priority to JP2000598510A priority patent/JP2002536452A/en
Priority to NZ513450A priority patent/NZ513450A/en
Priority to HU0105476A priority patent/HUP0105476A3/en
Priority to US09/913,226 priority patent/US7115590B1/en
Priority to TR2001/02313T priority patent/TR200102313T2/en
Priority to CN00806002A priority patent/CN1346360A/en
Priority to SI200030141T priority patent/SI1150988T1/en
Priority to AT00905043T priority patent/ATE241633T1/en
Priority to BR0008135-3A priority patent/BR0008135A/en
Priority to IL14464700A priority patent/IL144647A0/en
Priority to DZ000019A priority patent/DZ3007A1/en
Priority to ZA200106551A priority patent/ZA200106551B/en
Priority to NO20013910A priority patent/NO20013910L/en
Priority to HK02100897.2A priority patent/HK1039337B/en
Ceased legal-status Critical Current

Links

GBGB9903090.0A 1999-02-12 1999-02-12 Therapeutic compounds Ceased GB9903090D0 (en)

Priority Applications (30)

Application Number Priority Date Filing Date Title
GBGB9903090.0A GB9903090D0 (en) 1999-02-12 1999-02-12 Therapeutic compounds
IL14464700A IL144647A0 (en) 1999-02-12 2000-02-10 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (ir, cis)-4-(6-amino-9h-purin-9-yl) 2-cyclopentene-1-methanol as antiviral agents
PL350023A PL204458B1 (en) 1999-02-12 2000-02-10 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
JP2000598510A JP2002536452A (en) 1999-02-12 2000-02-10 Phosphoramidates of (1R, cis) -4- (6-amino-9H-purin-9-yl) -2-cyclopentene-1-methanol as antivirals, and mono-, di- and triphosphates
PCT/EP2000/001045 WO2000047591A1 (en) 1999-02-12 2000-02-10 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
KR1020017010198A KR20010102082A (en) 1999-02-12 2000-02-10 Phosphoramidate, and Mono-, Di-, and Tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as Aniviral Agents
AU26713/00A AU772478B2 (en) 1999-02-12 2000-02-10 Phosphoramidate, and mono-, DI-, and tri-phosphate esters of (1R,CIS)-4-(6-amino-9H-purin-9-YL)-2-cyclopentene-1- methanol as antiviral agents
TNTNSN00029A TNSN00029A1 (en) 1999-02-12 2000-02-10 ANALOGS OF (1R, cis) -4- (6-AMINO-9H-PURIN-9-YL) -2- CYCLOPENTENE-1-METHANOL AS ANTIVIRAL AGENTS
CZ20012908A CZ20012908A3 (en) 1999-02-12 2000-02-10 Analogs of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol
ES00905043T ES2200820T3 (en) 1999-02-12 2000-02-10 PHOSPHORAMIDATE, AND MONO-, DI- AND TRI-ESTERES PHOSPHATE OF (1R, CIS) -4- (6-AMINO-9H-PURIN-9-IL) -2-CYCLOPENTEN-1-METHANOL IN QUALITY OF ANTIVIRAL AGENTS.
CN 200410001601 CN1803810A (en) 1999-02-12 2000-02-10 Antiviral agents and preparing method thereof
DE60002986T DE60002986T2 (en) 1999-02-12 2000-02-10 PHOSPHORAMIDATE, MONO, DI, AND TRIPHOSPHATE ESTERS OF (1R, CIS) -4- (6-AMINO-9H-PURIN-9-YL) -2-CYCLOPENTENE-1-METHANOL AS AN ANTIVIRAL AGENT
PT00905043T PT1150988E (en) 1999-02-12 2000-02-10 (1R, CIS) -4- (6-AMINO-9H-PURIN-9-YL) -2-CYCLOPENTENE-1-METHANE ESTERS PHOSPHORAMIDATE AND ANTI-PARTICLE AGENTS
ARP000100596A AR031975A1 (en) 1999-02-12 2000-02-10 ANALOG COMPOUNDS OF (1R, CIS) -4- (6-AMINO-9H-PURIN-9-IL) -2-CYCLOPENTENE-1-METHANOL, PROCESS FOR PREPARATION, USE IN THE TREATMENT OF VIRAL INFECTIONS, AND PACKING THAT CONTAINS THEM
PE2000000100A PE20001462A1 (en) 1999-02-12 2000-02-10 (1R, CIS) -4- (6-AMINO-9H-PURIN-9-IL) -2-CYCLOPENTENE-1-METHANOL ANALOGS AS ANTIVIRAL AGENTS
DK00905043T DK1150988T3 (en) 1999-02-12 2000-02-10 Phosphoramidate and mono-, di- and triphosphoric esters of (1R, cis) -4- (6-amino-9H-purin-9-yl) -2-cyclopenten-1-methanol as antivirals
EP00905043A EP1150988B1 (en) 1999-02-12 2000-02-10 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
CA002362662A CA2362662A1 (en) 1999-02-12 2000-02-10 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
NZ513450A NZ513450A (en) 1999-02-12 2000-02-10 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R,cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene- 1-methanol useful as antiviral agents
HU0105476A HUP0105476A3 (en) 1999-02-12 2000-02-10 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents, process for preparation of the compounds and pharmaceutical compositions containing the same
US09/913,226 US7115590B1 (en) 1999-02-12 2000-02-10 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
TR2001/02313T TR200102313T2 (en) 1999-02-12 2000-02-10 As antiviral agents (1R, SíS) -4- (6-amino-9H-purin-9-yl) -2-cyclopentene-1-methanol n mono-, di and tri-phosphate esters and phosphoramidates
CN00806002A CN1346360A (en) 1999-02-12 2000-02-10 Phosphoramidate, and mono-di, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-YL)-2-cyclopentene-1-methanol as antiviral agents
SI200030141T SI1150988T1 (en) 1999-02-12 2000-02-10 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
AT00905043T ATE241633T1 (en) 1999-02-12 2000-02-10 PHOSPHORAMIDATE, MONO-, DI-, AND TRIPHOSPHATE ESTERS OF (1R, CIS)-4-(6-AMINO-9H-PURINE-9-YL)-2-CYCLOPENTENE-1-METHANOL AS ANTIVIRAL AGENTS
BR0008135-3A BR0008135A (en) 1999-02-12 2000-02-10 Compound, methods for treating a virus infection in a human and for treating a hepatitis B virus infection in a human, pharmaceutical composition, use of a compound, method for releasing a compound, patient package, process for preparation of a compound
DZ000019A DZ3007A1 (en) 1999-02-12 2000-03-09 Analogs of (1 R, CIS) -4- (6-amino-9H-purin-9-YL) -2-cyclopentene-1-methanol as antiviral agents.
ZA200106551A ZA200106551B (en) 1999-02-12 2001-08-08 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents.
NO20013910A NO20013910L (en) 1999-02-12 2001-08-10 Phosphoramidate, and mono-, di- and triphosphate esters of (1R, cis) - 4- (6-amino-9H-purin-9-yl) -2-cyclopenten-1-methanol as antivirals
HK02100897.2A HK1039337B (en) 1999-02-12 2002-02-05 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9903090.0A GB9903090D0 (en) 1999-02-12 1999-02-12 Therapeutic compounds

Publications (1)

Publication Number Publication Date
GB9903090D0 true GB9903090D0 (en) 1999-03-31

Family

ID=10847549

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9903090.0A Ceased GB9903090D0 (en) 1999-02-12 1999-02-12 Therapeutic compounds

Country Status (5)

Country Link
CN (1) CN1803810A (en)
GB (1) GB9903090D0 (en)
PE (1) PE20001462A1 (en)
TN (1) TNSN00029A1 (en)
ZA (1) ZA200106551B (en)

Also Published As

Publication number Publication date
CN1803810A (en) 2006-07-19
TNSN00029A1 (en) 2005-11-10
ZA200106551B (en) 2003-01-29
PE20001462A1 (en) 2001-01-02

Similar Documents

Publication Publication Date Title
HK1200316A1 (en) Therapeutic microfoams
GB9911863D0 (en) Therapeutic agents
GB9905010D0 (en) Therapeutic agents
GB9904786D0 (en) Therapeutic agents
GB9930570D0 (en) Therapy
GB9911881D0 (en) Therapeutic agents
GB9907243D0 (en) Therapy
GB9911802D0 (en) Therapeutic combination
GB9903476D0 (en) Therapeutic agents
GB9911803D0 (en) Therapeutic combination
GB9900222D0 (en) Therapeutic compounds
GB9911804D0 (en) Therapeutic combination
GB9914744D0 (en) Therapeutic agents
GB9808665D0 (en) Therapeutic compounds
GB9903119D0 (en) Therapeutic agents
GB9914745D0 (en) Therapeutic agents
GB9914742D0 (en) Therapeutic agents
GB9824897D0 (en) Therapeutic compounds
GB9902881D0 (en) Therapeutic agents
GB9914743D0 (en) Therapeutic agents
GB9808667D0 (en) Therapeutic compounds
GB9911238D0 (en) Therapeutic use
GB9915616D0 (en) Therapeutic agents
GB9907227D0 (en) Therapeutic compounds
GB9916886D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)